Synapse - Center for Hematologic Malignancies

Search Within

Center for Hematologic Malignancies

Results (13553)

Prevention of minimal residual disease in Ph+ ALL

Meeting Abstract

Appelmann, I.; DeStanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
Blood (2013)

A high complete remission rate can be achieved in older patients (age >= 60) with acute lymphoblastic leukemia regardless of induction intensities: Single-institution experience at Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Park, J. H.; Lee, S.; Devlin, S. M.; Tallman, M. S.; Douer, D.
Blood (2013)

Fulltext@MSK | Save

Predicting therapy-related acute myeloid leukemia by routine laboratory values: An analysis Of 126 patients with breast cancer referred for bone marrow biopsy at Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Stein, E. M.; Hsu, M.; Goldrich, A.; Kishtagari, A.; Devlin, S. M.; Tallman, M. S.; Soff, G. A.; Parameswaran, R.
Blood (2013)

Fulltext@MSK | Save

Frontline-treatment of acute lymphoblastic leukemia (ALL) in older adolescents and young adults (AYA) using a pediatric regimen is feasible: Toxicity results of the prospective US Intergroup Trial C10403 (Alliance)

Meeting Abstract

Advani, A. S.; Sanford, B.; Luger, S.; Devidas, M.; Larsen, E. C.; Liedtke, M.; Voorhees, P. M.; Foster, M. C.; Claxton, D. F.; Geyer, S.; more...
Blood (2013)

Fulltext@MSK | Save

Single-arm, open-label, multicenter study of deep molecular response (MR(4.5)) with nilotinib in adult patients (pts) with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (CML-CP): ENESTnext study update

Meeting Abstract

Mauro, M.; Radich, J.; Cortes, J. E.; Dakhil, S.; Keir, C.; Yi, S.; Wadleigh, M.; Oehler, V. G.; Ervin, T.; Goldberg, S.; more...
Blood (2013)

Fulltext@MSK | Save

Romidepsin is effective and well-tolerated in patients >= 60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): Analysis from phase 2 trials

Meeting Abstract

Shustov, A. R.; Coiffier, B.; Horwitz, S. M.; Sokol, L.; Pro, B.; Nielsen, T.; Wolfson, J.; Balser, B. E.; Eisch, R.; Popplewell, L.; more...
Blood (2013)

Fulltext@MSK | Save

Extramedullary disease is common in newly diagnosed AML but has no independent prognostic significance, including CNS involvement: Analysis of 3,522 AML patients treated on consecutive ECOG trials 1980-2008

Meeting Abstract

Ganzel, C.; Manola, J.; Douer, D.; Rowe, J. M.; Fernandez, H. F.; Paietta, E.; Litzow, M. R.; Lee, J. W.; Luger, S. M.; Lazarus, H. M.; more...
Blood (2013)

Fulltext@MSK | Save

Aurora A kinase is a novel therapeutic target in the myeloproliferative neoplasms

Meeting Abstract

Wen, Q. J.; Goldenson, B.; Malinge, S.; Stein, B. L.; Lasho, T. L.; Breyfogle, L.; Schultz, R.; Yang, Q.; Gilles-Gendre, L.; Koppikar, P.; more...
Blood (2013)

Fulltext@MSK | Save

Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): Updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Younes, A.; Flinn, I.; Berdeja, J.; Friedberg, J. W.; Casulo, C.; Thieblemont, C.; Morschhauser, F.; Westin, J. R.; Seetharam, S.; Hellemans, P.; more...
Blood (2013)

Fulltext@MSK | Save

Safety and efficacy of obinutuzumab (GA101) plus CHOP chemotherapy in first-line advanced diffuse large B-cell lymphoma: Results from the phase 2 gather study (GAO4915g)

Meeting Abstract

Zelenetz, A. D.; Mobasher, M.; Costa, L. J.; Flinn, I.; Flowers, C. R.; Kaminski, M. S.; Sandmann, T.; Trunzer, K.; Vignal, C.; Forero-Torres, A.
Blood (2013)

Fulltext@MSK | Save